Agenda - Thursday, January 16, 2020

7:30 - 8:00AM Registration & Check-in
8:00 - 8:45AM Keynote Address

Douglas Mann, MD, PhD

"Myocardial Remission: End of the Beginning or Beginning of the End?"

8:45 - 10:30AM

UCAR and Collaborators: (A) Clinical Innovation

Chairs: James Fang, U of Utah and Kirk Knowlton, Intermountain Healthcare

UTAH-INOVA Reverse Remodeling Stages. Palak Shah, MD, Inova

Non-invasive Pressure Volume Loops to Monitor and Diagnose Cardiac Recovery. Christopher Hayward, MD, Sydney, Australia

What happens long-term after we wean a cardiac assist device in heart failure patients? Snehal Patel, MD, Montefiore/Albert Einstein 

How to Start a Cardiac Recovery Clinical and Research Program: the Example of Allegheny, Manreet Kanwar, MD, Allegheny

10:30-11:00 AM Break
11:00AM - 12:30PM

UCAR and Collaborators: (B) Translational Innovation

Chairs: Robin Shaw, MD, PhD Cedars Sinai/U of Utah and Joseph Yost, PhD, U of Utah

Long non-coding RNAs and myocardial recovery mechanisms. Saumya Das, MD, MGH/Harvard

Innate immunity, macrophage heterogeneity and myocardial recovery. Kory Lavine, MD, PhD, Wash U

Regeneration in the human heart. Olaf Bergman, PhD, Karolinska, Sweden

12:30 - 1:30PM

Lunch - Moderated Posters Session

Committee Members: Rami Alharethi, MD, Mark Ibrahim, MD, Virginia Hebl, MD, and Eric Tuday, MD, PhD

1:30 - 2:45PM

Innovation in Myocardial Recovery: Bench to Bedside

Chairs: Jared Rutter, PhD, HHMI/U of Utah and Scott Summers, PhD, U of Utah

Mitochondria and myocardial recovery: lessons from disease models. Dipayan Chaudhuri, MD/PhD U of Utah

The role of metabolism in cardiac repair. Filio Billia, MD/PhD, U of Toronto

Role of the acute sterile immune response in cardiac rejuvenation by cell therapy. Jeff Molkentin, PhD, HHMI/U of Cincinnati

2:45 - 3:00PM Break
3:00 - 4:45PM

Innovation in Myocardial Recovery and MCS

Chairs: Boudi Kfoury, MD, Intermountain Healthcare and Antonio Cabrera, MD, Primary Children’s/U of Utah

Do we effectively unload the heart during chronic mechanical circulatory support? Should we? Nir Uriel, MD, Columbia

Exercise physiology during mechanical circulatory support: implications for myocardial recovery. Finn Gustafsson, MD, U of Copenhagen, Copenhagen, Denmark

What is a sufficient degree of cardiac improvement during LVAD to lead to favorable long-term outcomes after device weaning? Evgenij Potapov, MD, Berlin Heart Center, Germany

What are we learning from pediatric cardiac recovery programs? Melanie Everitt, MD, U of Colorado

4:45 - 6:00PM

“How To” – Focused Practical Discussions

  1. i) How to treat patients during LVAD support, ii) How to serially screen for cardiac recovery iii) Weaning criteria – INTERACTIVE CASES

DISCUSSION LEADERS: Melana Yuzefpolskaya, MD, Columbia, Iki Adachi, MD, Texas Children’s/Baylor, and Omar Wever Pinzon, MD, U of Utah 


  1. Myocardial Recovery: Ventricular Assist Device Explantation versus Decommissioning – INTERACTIVE CASES

DISCUSSION LEADERS: Ivan Netuka, MD, PhD, IKEM, Prague, U of Michigan and Craig Selzman, MD, U of Utah


  1. Patient-centered decision making and PRO in patients with “Recovered-EF”: provider and patient perspectives - PATIENTS LIVE PARTICIPATION.

DISCUSSION LEADERS: John Spertus, MD, UMKC and Josef Stehlik, MD, U of Utah


6:30 - 10:00PM

U-CARS Symposium Reception
University of Utah Rice Eccles Stadium


Previous Conferences



Officially endorsed by the Heart Failure Society of America. The opinions presented in this educational activity do not necessarily reflect the opinions or recommendations of the HFSA.